Literature DB >> 10894176

Investigation of estrogen status and increased stroke sensitivity on cerebral blood flow after a focal ischemic insult.

H V Carswell1, N H Anderson, J J Morton, J McCulloch, A F Dominiczak, I M Macrae.   

Abstract

Recently the authors have shown that female stroke-prone spontaneously hypertensive rats (SHRSPs) in proestrus (high endogenous estrogen), sustain more than 20% smaller infarcts after middle cerebral artery occlusion (MCAO) compared with SHRSPs in metestrus (low endogenous estrogen). Because estrogen has vasodilator properties, the authors investigated whether the estrous state influences cerebral blood flow (CBF) after MCAO. CBF was measured 2.5 hours after a distal MCAO by [14C]iodo-antipyrine autoradiography in conscious SHRSPs either in metestrus or in proestrus. There were no significant differences in CBF when analyzed either at predetermined anatomic regions or by cumulative distribution analysis of areas with flow <25 mL/100 g/min. As a positive internal control, the authors compared results in SHRSPs with those in their normotensive reference strain, Wistar Kyoto rat. SHRSPs displayed more severe and widespread ischemia than Wistar Kyoto rats. Thus, the absence of demonstrable CBF differences between estrous states appears to be unrelated to the CBF measurement paradigm. In conclusion, the smaller infarct size afforded in proestrus in SHRSPs is unlikely to be due to an influence on CBF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894176     DOI: 10.1097/00004647-200006000-00005

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  15 in total

Review 1.  Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia.

Authors:  David W Howells; Michelle J Porritt; Sarah S J Rewell; Victoria O'Collins; Emily S Sena; H Bart van der Worp; Richard J Traystman; Malcolm R Macleod
Journal:  J Cereb Blood Flow Metab       Date:  2010-05-19       Impact factor: 6.200

2.  IL-4 Is Required for Sex Differences in Vulnerability to Focal Ischemia in Mice.

Authors:  Xiaoxing Xiong; Lijun Xu; Liang Wei; Robin E White; Yi-Bing Ouyang; Rona G Giffard
Journal:  Stroke       Date:  2015-06-30       Impact factor: 7.914

Review 3.  The assessment of non-feminizing estrogens for use in neuroprotection.

Authors:  Kun Don Yi; Evelyn Perez; Shaohua Yang; Ran Liu; Douglas F Covey; James W Simpkins
Journal:  Brain Res       Date:  2010-11-25       Impact factor: 3.252

4.  Angiotensin II type 2 receptor stimulation with compound 21 improves neurological function after stroke in female rats: a pilot study.

Authors:  Wael Eldahshan; Tauheed Ishrat; Bindu Pillai; Mohammed A Sayed; Abdulrahman Alwhaibi; Abdelrahman Y Fouda; Adviye Ergul; Susan C Fagan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-01       Impact factor: 4.733

Review 5.  Neuroprotection with non-feminizing estrogen analogues: an overlooked possible therapeutic strategy.

Authors:  James W Simpkins; Timothy E Richardson; Kun Don Yi; Evelyn Perez; Douglas F Covey
Journal:  Horm Behav       Date:  2012-04-03       Impact factor: 3.587

Review 6.  Window of opportunity: estrogen as a treatment for ischemic stroke.

Authors:  Ran Liu; Shao-Hua Yang
Journal:  Brain Res       Date:  2013-01-20       Impact factor: 3.252

7.  Gender Disparities among Intracerebral Hemorrhage Patients from a Multi-ethnic Population.

Authors:  Alexandra Galati; Sage L King; Kazuma Nakagawa
Journal:  Hawaii J Med Public Health       Date:  2015-09

Review 8.  Age-related changes in brain support cells: Implications for stroke severity.

Authors:  Farida Sohrabji; Shameena Bake; Danielle K Lewis
Journal:  Neurochem Int       Date:  2013-06-28       Impact factor: 3.921

Review 9.  Stroke neuroprotection: oestrogen and insulin-like growth factor-1 interactions and the role of microglia.

Authors:  F Sohrabji; M Williams
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

10.  Estrous cycle-dependent neurovascular dysfunction induced by angiotensin II in the mouse neocortex.

Authors:  Carmen Capone; Josef Anrather; Teresa A Milner; Costantino Iadecola
Journal:  Hypertension       Date:  2009-06-08       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.